Swiss pharmaceutical company Acino and multinational pharmaceutical company Aspen Pharmacare and its subsidiaries have signed an agreement for Acino to acquire six South African medicines for more than R1.8-billion. The acquired medicines are used for the treatment of gastroenterology, erectile dysfunction and cardiovascular diseases.